Periodic Reporting for period 1 - ScrIntOR (Genome-wide CRISPR/Cas9 screen in intestinal organoids for identification and molecular characterization of therapeutic targets to enhance tissue regeneration)

Around 3 million people in Europe are affected by inflammatory bowel disease (IBD), a devastating condition characterized by chronic inflammation of the gastrointestinal tract which causes severe damage to the intestinal epithelium. Current standard treatment of IBD focuses...